NetBio

Peter Vallone

Vallone recently authored a review of the field, noting that fully integrated rapid systems have special advantages.

Title: Unitary biochip providing sample-in to results-out processing and methods of manufacture.
Patent Number: 8,720,036
Filed: Sept. 8, 2011

GE Healthcare Life Sciences and NetBio this week named several laboratories participating in a comprehensive developmental validation of the DNAscan Rapid DNA Analysis System.

Bioneer has been awarded US Patent No, 8,427,643, "Real-time PCR monitoring apparatus."
Hanee Park, Il Kyu Choi, and Han Oh Park are named as inventors.

Life Technologies said this week that it has become the exclusive worldwide distributor for LGC Forensics' recently launched ParaDNA platform, a portable DNA testing system designed to determine the quality of human DNA more quickly and efficiently than existing methods.

Scientists from Network Biosystems have published research demonstrating that the company's rapid, point-of-care system for diagnosing and differentiating Chlamydia trachomatis strains achieved greater sensitivity and specificity than a commercially available PCR-based

This article has been updated from a previous version to provide information regarding the name of ZyGem's DNA testing platform.

GE Healthcare and Network Biosystems this week announced a collaboration to commercialize rapid DNA analysis products for forensic applications.

NEW YORK (GenomeWeb News) – GE Healthcare Life Sciences and NetBio said on Monday they will commercialize new products for DNA sample collection and analysis for the forensics market.

Medical Diagnostics Laboratories has been awarded US Patent No. 8,206,930, "Compositions and methods for detecting Borrelia afzelii."
Melanie Feola, Martin Adelson, Eli Mordechai, and Lisa Novak are named as inventors on the patent.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.